Research in heart yield and translational medicine最新文献

{"title":"Long-Term Changes and Disparities in the Global Burden of Rheumatic Heart Disease between 1990 and 2021: An Analysis Based on the Global Burden of Disease (GBD) Study.","authors":"Mohammad Sadegh Talebi Kahdouei, Hosein Ghasempour, Fatemeh Aghaei, Elahe Vafaei, Behnaz Sohrabi, Ehsan Aghaei Moghadam, Negin Rahimidanesh, Ali Dahmardeh Ei, Mojataba Shurmij","doi":"10.18502/jthc.v21i1.21283","DOIUrl":"10.18502/jthc.v21i1.21283","url":null,"abstract":"<p><strong>Highlights: </strong>Global age-standardized mortality and DALY rates of rheumatic heart disease (RHD) declined substantially between 1990 and 2021 (56% and 53%, respectively), reflecting major progress in disease control. Years of life lost (YLL) decreased by 59%, whereas years lived with disability (YLD) increased by 11%, indicating a shift from fatal outcomes toward chronic nonfatal burden. Marked sociodemographic disparities persist, with low- and low-middle-SDI regions-particularly South Asia-bearing a disproportionate share of global RHD deaths and DALYs. This comprehensive GBD 2021 analysis provides a long-term comparative assessment of fatal and nonfatal RHD burden across SDI levels and regions, informing targeted, equity-focused health policy and long-term care strategies.</p><p><strong>Background: </strong>Rheumatic heart disease (RHD) remains a major cause of preventable cardiovascular morbidity and mortality, particularly in low- and middle-income countries. Despite the World Health Organization's 2018 resolution calling for global elimination of RHD, substantial disparities in disease burden persist across regions and levels of socio-economic development. While previous studies have reported global trends, a clear comparative assessment of long-term changes in both fatal and non-fatal RHD burden across socio-demographic and geographic regions remains limited. This study aimed to assess long-term changes in the global burden of RHD between 1990 and 2021, with a specific focus on regional and socio-demographic disparities, using the most recent estimates from the Global Burden of Disease (GBD) 2021 study. We additionally assessed temporal trends across Socio-demographic Index (SDI) groups and GBD regions, with a specific focus on fatal (YLL) and non-fatal (YLD) components of disease burden.</p><p><strong>Methods: </strong>We conducted a secondary analysis of model-based estimates from the Global Burden of Disease (GBD) 2021 study to assess the burden of RHD between 1990 and 2021. Metrics included age-standardized and all-age incidence, prevalence, mortality, years of life lost (YLL), years lived with disability (YLD), and disability-adjusted life years (DALY). Data were stratified by five Socio-demographic Index (SDI) levels and 13 global regions. Estimates were produced using DisMod-MR 2.1 and CODEm and are reported as means with 95% uncertainty intervals (UIs).</p><p><strong>Results: </strong>Globally, age-standardized mortality and DALY rates for RHD declined by 56% and 53%, respectively, from 1990 to 2021. YLL decreased by 59%, while YLD rose by 11%, indicating a shift toward chronic non-fatal burden. For instance, the global age-standardized mortality rate fell from 9.1 (95% UI: 8.4-9.8) to 4.0 (3.6-4.5) per 100,000. High and high-middle SDI regions achieved the greatest reductions across all indicators. In contrast, low and low-middle-SDI regions experienced persistently high absolute deaths and DALYs, with South Asia ","PeriodicalId":524224,"journal":{"name":"Research in heart yield and translational medicine","volume":"21 1","pages":"50-70"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13614909/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149067226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Systems-Level in Silico Bioinformatic Profiling Identifies Key Hub Genes and Potential Therapeutic Targets in Atrial Fibrillation without Overt Comorbidity.","authors":"Fadhlan Abdur Rahman, Suryono Suryono, Aditha Satria Maulana, Pipiet Wulandari","doi":"10.18502/jthc.v21i1.21282","DOIUrl":"10.18502/jthc.v21i1.21282","url":null,"abstract":"<p><strong>Highlights: </strong>Systems-level bioinformatics delineates the molecular architecture of AF without overt comorbidity.Network analysis reveals a highly interconnected ion-channel-centered interactome.DMNC topology prioritizes 10 mechanistically relevant hub genes governing atrial electrophysiology.Sodium and potassium channel modulators emerge as dominant drivers of arrhythmogenic susceptibility.These findings establish a molecular framework for precision stratification in isolated AF.</p><p><strong>Background: </strong>Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is associated with substantial morbidity and mortality. AF occurring in individuals without structural heart disease or conventional risk factors, currently referred to as AF without overt comorbidity, remains poorly understood. Genetic susceptibility is thought to contribute, but the underlying molecular mechanisms are incompletely defined. This study aimed to identify key genes and biological processes associated with AF without overt comorbidity using an in-silico bioinformatics approach.</p><p><strong>Methods: </strong>Genes associated with AF without overt comorbidity were retrieved from the GeneCards database using a knowledge-based, database-driven strategy. Functional enrichment analysis of Gene Ontology biological processes was performed using WebGestalt. Protein-protein interaction (PPI) analysis was conducted using STRING and visualized in Cytoscape. Hub genes were identified exclusively using the Density of Maximum Neighborhood Component (DMNC) algorithm via the CytoHubba plugin. Three-dimensional protein structures of selected hub genes were modeled using SWISS-MODEL and evaluated using PROCHECK for exploratory structural characterization.</p><p><strong>Results: </strong>Eighty-one genes associated with AF without overt comorbidity were identified. PPI analysis demonstrated significant interaction enrichment (P<1.0×10^-16), indicating a nonrandom and biologically coherent network. Functional enrichment analysis revealed cardiac muscle cell action potential and cardiac muscle contraction as the most significantly enriched biological processes. Ten hub genes were identified based on DMNC ranking. Among these, GPD1L, SCN1B, SCN4B, and KCNE2 showed central network positions and acceptable stereochemical quality in exploratory structural evaluation.</p><p><strong>Conclusion: </strong>This in silico study identifies candidate genes and biological processes potentially involved in AF without overt comorbidity. The findings are hypothesis generating and warrant further functional and clinical validation.</p>","PeriodicalId":524224,"journal":{"name":"Research in heart yield and translational medicine","volume":"21 1","pages":"40-49"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13614903/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149067249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Attenuation of Residual Antibiotics Using Vitamin C in Homograft Heart Valves.","authors":"Ellen Sepanian, Orkideh Olang, Mohsen Heydari, Seyed Amirhosein Tavakoli, Seyed Kazem Hosseini, Hamid Goodarzi, Alireza Heidary Rouchi","doi":"10.18502/jthc.v21i1.21277","DOIUrl":"10.18502/jthc.v21i1.21277","url":null,"abstract":"<p><strong>Highlights: </strong>To use Vitamin C during processing of homograft heart valve can reduce the amount of residual antibiotics and prevents its consequences.</p><p><strong>Objective: </strong>The removal of residual antibiotics from whole homograft tissues after disinfection is a matter of concern. To avoid bacteriostasis, which causes falsely negative culture results, we investigated the effectiveness of a novel method applicable to whole homografts.</p><p><strong>Methods: </strong>Thirty homografts, assessed as unsuitable for transplantation, were obtained from 24 deceased donors. Fourteen days after freezing, each homograft was thawed and divided lengthwise into 2 halves, with one serving as an unexposed control and the other as an exposed sample. Exposure was conducted using 400 μg/mL vitamin C. Five-step microbiological assays were performed using direct tissue samples and cryopreservation solution after thawing. The presence of residual antibiotics in tissue homogenates and cryopreservation solution was assessed by an agar diffusion test on seeded plates with 8 virulent strains. The effect of the intervention was determined by comparing the inhibition zones of exposed and unexposed tissue homogenates.</p><p><strong>Results: </strong>Blood culture results from all donors were negative. The initial contamination rate was 13.3%, and the isolates were not detected after disinfection. Thawed tissues that were not exposed to vitamin C all yielded negative culture results, whereas one tissue sample exposed to vitamin C had a positive result (Pantoea eucrina). The diameter of the inhibition zone in seeded plates was 14.4% smaller with tissue exposed to vitamin C than that of controls (P=0.021).</p><p><strong>Conclusion: </strong>The retention of antibiotics and carryover effect are unavoidable. Vitamin C can break down antimicrobial molecules and produce soluble by-products, which leads to a diminished amount of residual antimicrobials and a higher probability of detecting microorganisms in post-disinfection cultures.</p>","PeriodicalId":524224,"journal":{"name":"Research in heart yield and translational medicine","volume":"21 1","pages":"1-11"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13614907/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149067288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Is Ferroptosis and Oxidative Stress Involved in NSTEMI Patient's?","authors":"Ali Mirzaee, Maryam Mehrpooya, Akram Ranjbar, Sajad Naghdi, Afsaneh Familmotaghi, Seyed Saman Talebi, Seyed Kianoosh Hosseini","doi":"10.18502/jthc.v21i1.21281","DOIUrl":"10.18502/jthc.v21i1.21281","url":null,"abstract":"<p><strong>Highlights: </strong>Ferroptosis (iron-dependent lipid peroxidation-driven cell death) is implicated in ischemic injury.NSTEMI patients showed significantly higher oxidative stress (↑LPO) and iron overload (↑iron, ↑ferritin) vs controls.Antioxidant defenses were reduced in NSTEMI (↓TAC, ↓TTG, ↓SOD, ↓GPx activity).This biomarker pattern supports ferroptosis activation contributing to myocardial injury in NSTEMI.</p><p><strong>Background: </strong>Ischemic heart disease is the leading cause of death worldwide. Oxidative stress plays a key role in myocardial infarction (MI). Ferroptosis, a type of iron-dependent regulated cell death caused by lipid peroxide accumulation, has been identified as a key mechanism in ischemic injury. This study aimed to investigate the association between oxidative stress and ferroptosis in patients with non-ST-segment-elevation myocardial infarction (NSTEMI).</p><p><strong>Methods: </strong>In this case-control study, 25 patients with NSTEMI and 25 controls were included. In serum samples, cardiac markers (troponin I and CK-MB), oxidative stress biomarkers including lipid peroxidation (LPO), total antioxidant capacity (TAC), total thiol groups (TTG), superoxide dismutase (SOD) activity, glutathione peroxidase (GPx) activity, and iron and ferritin levels were measured.</p><p><strong>Results: </strong>In patients with NSTEMI, serum levels of cardiac markers (troponin I and CK-MB), LPO, iron, and ferritin were significantly higher than in controls. In contrast, TAC, TTG, and SOD and GPx activities were significantly lower in patients with NSTEMI.</p><p><strong>Conclusion: </strong>This study demonstrated a possible role of oxidative stress in the pathophysiology of NSTEMI. Elevated iron and LPO levels and reduced GPx activity may contribute to cardiac cell death through ferroptosis.</p>","PeriodicalId":524224,"journal":{"name":"Research in heart yield and translational medicine","volume":"21 1","pages":"32-39"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13614900/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149067002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Closure of Sinus Venosus Atrial Septal Defects with Transcatheter Balloon-Expandable Stents: A Single-Center Case Series.","authors":"Hojjat Mortezaeian, Mohammad Hossein Mozafary Bazargany, Ali Reza Salmanipour, Amir Banazade Dardashty","doi":"10.18502/jthc.v21i1.21287","DOIUrl":"10.18502/jthc.v21i1.21287","url":null,"abstract":"<p><strong>Background: </strong>Sinus venosus atrial septal defect (SVASD) is a congenital heart defect involving an opening between the superior vena cava (SVC) and the right upper pulmonary vein (RUPV). Surgical closure is the standard treatment. Nonetheless, it is more complex than secundum ASD reconstruction and is associated with higher complication rates. Transcatheter closure is an emerging alternative.</p><p><strong>Methods: </strong>We report 5 cases of transcatheter SVASD closure and 1 case of failure requiring surgical intervention. All patients underwent preprocedural computed tomography angiography to assess defect size and location and optimal stent dimensions. SVC stenting was performed using balloon-expandable stents, followed by RUPV angioplasty if necessary.</p><p><strong>Results: </strong>Final angiograms and pressure measurements in the SVC, RUPV, and right atrium confirmed the absence of residual shunt and pulmonary venous obstruction. Stent migration to the pulmonary artery occurred in 1 patient, necessitating surgical retrieval and defect closure.</p><p><strong>Conclusions: </strong>Balloon expansion testing is not mandatory before stent implantation. If RUPV obstruction occurs, flow can be reestablished via ballooning or stent implantation within the RUPV, and associated mild residual shunts may resolve spontaneously.</p>","PeriodicalId":524224,"journal":{"name":"Research in heart yield and translational medicine","volume":"21 1","pages":"103-110"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13614902/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149066305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of Vitamin B12 and Folate Deficiency with Vasovagal Syncope: A Case-Control Study.","authors":"Arya Aminorroaya, Ali Vasheghani-Farahani, Hamed Tavolinejad, Zahra Aryan, Somayeh Yadangi, Ali Bozorgi, Saeed Sadeghian, Mohammadali Boroumand, Masud Yunesian, Masih Tajdini","doi":"10.18502/jthc.v21i1.21279","DOIUrl":"10.18502/jthc.v21i1.21279","url":null,"abstract":"<p><strong>Highlights: </strong>Vitamin B12 and folate status were evaluated in adults with vasovagal syncope.No association was found between vitamin deficiency and vasovagal syncope overall.Lower vitamin B12 levels were observed in patients with frequent syncope.</p><p><strong>Background: </strong>Clinical evidence suggests an association between vitamin B12 deficiency and vasovagal syncope (VVS) in pediatric patients. This study investigated the association of vitamin B12 and folate deficiency with VVS in adults.</p><p><strong>Methods: </strong>In this case-control study, adult patients with VVS who presented to the tertiary syncope unit for head-up tilt table testing comprised the case group. Age- and sex-matched individuals without syncope history from the population-based Tehran Cohort Study served as the control group. Exclusion criteria included but were not limited to the use of vitamin B supplements, carbamazepine, or phenobarbital, and sleeve gastrectomy. Serum vitamin B12, folate, and homocysteine levels were measured and compared.</p><p><strong>Results: </strong>From February 2020 through February 2021, 44 patients comprised the case group, matched with 44 controls (mean age, 37.9 years; 23 [52.3%] females in each group). No statistically significant difference existed between the groups in vitamin B12 or folate deficiency or serum levels. Serum vitamin B12 levels were significantly lower in patients with frequent VVS (≥3 lifetime episodes) than in patients with infrequent VVS (<3 lifetime episodes) (233.8 [80.7] vs 305.2 [118.1] pg/mL; P=0.042), and the association remained significant after adjustment for confounders (P=0.026).</p><p><strong>Conclusion: </strong>No association existed between vitamin B12 or folate deficiency or serum levels and VVS. Frequent VVS was associated with lower serum vitamin B12 levels than infrequent VVS.</p>","PeriodicalId":524224,"journal":{"name":"Research in heart yield and translational medicine","volume":"21 1","pages":"12-19"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13614908/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149067277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Factors Associated with Arrhythmia in Patients with ST Segment Elevation Myocardial Infarction: A Single-Center Cross-Sectional Study.","authors":"Rizki Hilman, Adi Purnawarman, Haris Munirwan, Muhammad Ridwan, Herlina Dimiati","doi":"10.18502/jthc.v21i1.21280","DOIUrl":"10.18502/jthc.v21i1.21280","url":null,"abstract":"<p><strong>Highlights: </strong>Arrhythmia occurred in 26.5% of hospitalized STEMI patients in this cohort.Higher Killip class, TIMI, GRACE, reduced TAPSE, renal dysfunction, and hyperkalemia were associated with arrhythmia in unadjusted analysis.After multivariable adjustment, Killip class was the only independent predictor of in-hospital arrhythmia.Killip class I reduced arrhythmic risk by around 60% compared with higher classes.</p><p><strong>Background: </strong>Arrhythmia is a common and clinically significant complication during hospitalization for ST-segment elevation myocardial infarction (STEMI). This study aimed to identify factors associated with the occurrence of arrhythmia in the acute phase of STEMI.</p><p><strong>Methods: </strong>This single-center cross-sectional study was conducted among adult patients hospitalized with STEMI. Demographic and clinical variables, including cardiovascular risk factors and disease severity (Killip class, Thrombolysis in Myocardial Infarction [TIMI] score, and Global Registry of Acute Coronary Events [GRACE] score), were obtained from medical records. The primary outcome was in-hospital arrhythmia, defined as documented atrial or ventricular tachyarrhythmia or clinically significant bradyarrhythmia. Factors associated with arrhythmia were assessed using bivariate analyses followed by multivariable logistic regression.</p><p><strong>Results: </strong>This study involved 113 patients, with a mean age of 56.4 (11.1) years. Arrhythmia occurred in 26.5% (30 patients) during hospitalization. In bivariate analyses, arrhythmia was associated with higher Killip class (P<0.001), higher TIMI score (P=0.005), higher GRACE score (P=0.001), lower tricuspid annular plane systolic excursion (P=0.002), elevated serum potassium level (P=0.010), and impaired renal function, reflected by higher urea (P=0.005) and creatinine levels (P=0.004). After multivariable adjustment, only Killip class remained independently associated with arrhythmia: patients presenting with Killip class I had a significantly lower risk of arrhythmia than those with higher Killip classes (adjusted OR, 0.404; 95% CI, 0.20 to 0.80; P=0.009).</p><p><strong>Conclusion: </strong>In hospitalized patients with STEMI, arrhythmic risk is chiefly driven by early clinical severity. Killip class is a simple bedside predictor of in-hospital arrhythmia and can aid early risk stratification and monitoring.</p>","PeriodicalId":524224,"journal":{"name":"Research in heart yield and translational medicine","volume":"21 1","pages":"20-31"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13614905/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149066674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Primary Malignant Pericardial Mesothelioma Manifesting as Constrictive Pericarditis with Atypical Imaging Features: A Case Report.","authors":"Ehsan Shahverdi, Gayathri Santhosh Kumar, Carsten Schneider, Mathias Lange","doi":"10.18502/jthc.v21i1.21286","DOIUrl":"10.18502/jthc.v21i1.21286","url":null,"abstract":"<p><strong>Background: </strong>Primary malignant pericardial mesothelioma (PMPM) is an exceptionally rare and aggressive cancer originating from the mesothelial lining of the heart. This distinct and challenging oncologic entity is typically discovered at an advanced stage due to vague, nonspecific symptoms-most commonly chest pain and dyspnea. These clinical features often mimic more common conditions, making early detection difficult. Diagnostic confirmation usually requires detailed histopathologic analysis, often obtained through surgical procedures or postmortem examination. The disease's elusive nature and rapid progression contribute to its generally poor prognosis, underscoring the need for heightened clinical awareness and advanced diagnostic strategies.</p><p><strong>Case report: </strong>A 58-year-old patient was diagnosed with malignant pericardial mesothelioma, which progressed rapidly and resulted in death within 1 month of diagnosis.</p><p><strong>Conclusions: </strong>PMPM remains a rare and highly aggressive cancer characterized by swift, fatal progression. Diagnosis is difficult because of nonspecific clinical symptoms. Accurate diagnosis is essential for subsequent treatment planning. Nonetheless, limited treatment alternatives, coupled with the minimal effectiveness of immunotherapy in advanced disease, highlight the pressing need for further research and therapeutic advances.</p>","PeriodicalId":524224,"journal":{"name":"Research in heart yield and translational medicine","volume":"21 1","pages":"98-102"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13614906/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149067267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Successful Pregnancy in Chronic Obstructive Pulmonary Hypertension Secondary to Pulmonary and Cardiac Hydatid Cysts: A Case Report.","authors":"Farnaz Ahmadi, Raha Parnia, Bahamin Astani, Mohammad-Sadegh Keshmiri, Shakiba Khodadad, Hakimeh Sheikhzadeh, Zahra Daneshmandi, Faezeh Ansari, Mahsa Riahi, Sima Noorali, Hannaneh Yousefi-Koma, Babak Sharif-Kashani, Shadi Shafaghi","doi":"10.18502/jthc.v21i1.21288","DOIUrl":"10.18502/jthc.v21i1.21288","url":null,"abstract":"<p><strong>Highlights: </strong>Pregnancy is typically contraindicated in women with pulmonary hypertension (PH) due to severe mortality risks.A 31-year-old woman with PH, secondary to previous hydatid cysts, conceived against medical advice while on medical therapy. She successfully delivered via emergency C-section at 37 weeks.Her case highlights those high-risk pregnancies complicated by PH can be successfully managed through prompt, multidisciplinary care at a specialized tertiary center.</p><p><strong>Background: </strong>Pregnancy in women with pulmonary hypertension (PH) is contraindicated because of high mortality rates associated with physiological changes, particularly in the peripartum and postpartum periods. Termination is recommended early if pregnancy occurs. Consequently, clinical experience with continued pregnancy in patients with PH is scarce.</p><p><strong>Case presentation: </strong>A 31-year-old woman was diagnosed with multiple bilateral pulmonary and right ventricular hydatid cysts. After surgical and pharmacologic treatments, she developed PH due to pulmonary artery obstruction 8 years later. Because of her condition, she was ineligible for surgery and received medical therapy, including tadalafil, bosentan, and eplerenone. After 3 years, she conceived despite advice to avoid pregnancy. At 37 weeks' gestation, she underwent successful emergency cesarean delivery because of maternal dyspnea and tachycardia.</p><p><strong>Conclusion: </strong>Prompt treatment and regular follow-up in a tertiary care center using a multidisciplinary approach are crucial for managing pregnant patients with PH.</p>","PeriodicalId":524224,"journal":{"name":"Research in heart yield and translational medicine","volume":"21 1","pages":"111-115"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13614904/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149067264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Heart Failure with Preserved Ejection Fraction: Challenges and Current Approaches.","authors":"Kaushal Sikka","doi":"10.18502/jthc.v21i1.21285","DOIUrl":"10.18502/jthc.v21i1.21285","url":null,"abstract":"<p><strong>Background: </strong>Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome associated with substantial morbidity, mortality, and impaired quality of life. Despite its rising prevalence, particularly among older adults and women, HFpEF has historically been characterized as a \"therapeutic graveyard\" because of decades of inconclusive or neutral clinical trials.</p><p><strong>Methods: </strong>A secondary qualitative analysis of the literature indexed in PubMed, Scopus, and Embase from January 2018 through June 2025 was conducted. Randomized controlled trials, systematic reviews, meta-analyses, guideline statements, and high-quality observational studies were included. Data were extracted and synthesized thematically across five domains: epidemiology, pathophysiology, diagnostic strategies, therapeutic approaches, and future directions.</p><p><strong>Results: </strong>Epidemiological data confirm increasing global prevalence, driven by aging demographics and clustering of comorbidities such as obesity, hypertension, diabetes, and atrial fibrillation. Pathophysiological insights highlight a complex, multiorgan syndrome with distinct phenotypes. Diagnostic accuracy remains hampered by overlapping comorbidities, limited biomarker sensitivity in obese or renally impaired patients, and heterogeneity in imaging findings. Artificial intelligence and machine learning approaches are emerging but not yet established in clinical care. Therapeutically, sodium-glucose cotransporter-2 (SGLT2) inhibitors represent the first pharmacologic agents to consistently reduce hospitalization and improve outcomes in HFpEF, while lifestyle modification, rehabilitation, and device-based interventions offer complementary benefits. Emerging strategies emphasize precision medicine, digital health, and biomarker-driven stratification.</p><p><strong>Conclusion: </strong>HFpEF remains a major unexplained challenge in cardiovascular management. The efficacy of sodium-glucose cotransporter-2 inhibitors can mark a paradigm shift; however, significant weaknesses persist in diagnostic and therapeutic areas. Further progress depends on phenotype-specific, multimodal, and patient-centered strategies that combine clinical care, digital innovation, and molecular research.</p>","PeriodicalId":524224,"journal":{"name":"Research in heart yield and translational medicine","volume":"21 1","pages":"85-97"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13614901/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149066754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}